Skip to main content
. Author manuscript; available in PMC: 2015 May 4.
Published in final edited form as: Circulation. 2010 Dec 15;123(4):e18–e209. doi: 10.1161/CIR.0b013e3182009701

Table 6-2.

Modifiable Stroke Risk Factors

Factor Prevalence, % Population-
Attributable Risk, %*
RR
CVD
CHD143
  Men 8.4 5.8 1.73 (1.68–1.78)161
  Women 5.6 3.9 1.55 (1.17–2.07)162
Heart failure143
  Men 2.6 1.4
  Women 2.1 1.1
Peripheral arterial disease 4.9 3.0
Hypertension144
  Age 50 y 20 40 4.0
  Age 60 y 30 35 3.0
  Age 70 y 40 30 2.0
  Age 80 y 55 20 1.4
  Age 90 y 60 0 1.0
Cigarette smoking 25 12–18 1.8
Diabetes mellitus 7.3 5–27 1.8–6
Asymptomatic carotid stenosis 2–8148154 2–7 2.0162
Atrial fibrillation (nonvalvular)145,146
  Age 50–59 y 0.5 1.5 4.0
  Age 60–69 y 1.8 2.8 2.6
  Age 70–79 y 4.8 9.9 3.3
  Age 80–89 y 8.8 23.5 4.5
Sickle cell disease 0.25 (of blacks)155 200–400163§
Dyslipidemia
  High total cholesterol 25156 15 2.0 for men and for women <55 y of age
  Low HDL cholesterol 25156 10 1.5–2.5 for men
Dietary factors
  Na intake 2300 mg 75–90 Unknown Unknown
  K intake 4700 mg 90–99157 Unknown Unknown
Obesity 17.9158 12–20 1.75–2.37164,165
Physical inactivity147 25 30 2.7
Postmenopausal hormone therapy 20159 (women 50–74 y of age)160 7 1.463

RR indicates relative risk; CVD, cardiovascular disease; CHD, coronary heart disease; HDL, high-density lipoprotein.

Data derived from Hart et al166,167 and van Walraven et al.168 Stroke includes both ischemic and hemorrhagic stroke. Cardiovascular disease includes coronary heart disease, heart failure, and peripheral arterial disease.

*

Population-attributable risk is the proportion of ischemic stroke in the population that can be attributed to a particular risk factor (see text for formula).

Calculated on the basis of point estimates of referenced data provided in the table. For peripheral arterial disease, calculation was based on average relative risk for men and women.

Calculated based on referenced data provided in the table or text.

§

Relative to stroke risk in children without sickle cell disease.

Adapted from Goldstein et al.169